Petco Health and Wellness Company, Inc. Class A Common Stock (WOOF) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 27	$0.07	$0.15	+114.3%	—	$1.5B	—
Q1 27	$0.03	$0.03	0.0%	—	$1.5B	—
Q4 26	$0.04	$0.04	0.0%	—	$1.5B	—
Q3 26	$0.02	$0.04	+100.0%	—	$1.5B	—
Q2 26	$0.02	$0.07	+250.0%	—	$1.5B	—
Q1 26	-$0.01	$0.02	+300.0%	—	$1.5B	—
Q4 25	$0.01	$0.02	+100.0%	—	$1.6B	—
Q3 25	-$0.04	-$0.02	+50.0%	—	$1.5B	—
Q2 25	-$0.03	-$0.02	+33.3%	—	$1.5B	—
Q1 25	-$0.06	-$0.04	+33.3%	—	$1.5B	—
Q4 24	$0.01	$0.02	+100.0%	—	$1.7B	—
Q3 24	$0.02	-$0.05	-350.0%	—	$1.5B	—
Q2 24	$0.06	$0.06	0.0%	—	$1.5B	—
Q1 24	$0.05	$0.06	+20.0%	—	$1.6B	—
Q4 23	$0.24	$0.23	-4.2%	—	$1.6B	—
Q3 23	$0.16	$0.16	0.0%	—	$1.5B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY26	—	$0.03	—	—	$6B	—
FY25	—	-$0.37	—	—	$6.1B	—
FY24	—	-$4.78	—	—	$6.3B	—
FY23	—	$0.34	—	—	$6B	—
FY22

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	$4.4B	$4.4B	$4.9B	$5.8B	$6B	$6.3B	$6.1B	$6B
YoY change	—	+0.96%	+11%	+18%	+3.94%	+3.63%	-2.22%	-2.53%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	4.4B	4.4B	4.9B	5.8B	6B	6.3B	6.1B	6B
Cost of revenue	2.5B	2.5B	2.8B	3.4B	3.6B	3.9B	3.8B	3.7B
Gross profit	1.9B	1.9B	2.1B	2.4B	2.4B	2.4B	2.3B	2.3B
Gross margin	43.4%	43%	42.8%	41.8%	40.2%	37.6%	38%	38.7%
Research & development	—	—	—	—	—	—	—	—
Selling, general & administrative	1.7B	1.8B	1.9B	2.2B	2.2B	2.3B	2.3B	2.2B
Operating expenses	1.7B	1.8B	1.9B	2.2B	2.2B	2.3B	2.3B	2.2B
Operating income	158.5M	129.6M	194.4M	266.1M	225.6M	42.2M	7.1M	120.4M
Operating margin	3.61%	2.92%	3.95%	4.58%	3.74%	0.67%	0.12%	2.02%
Non-operating income, net	-373.6M	-19M	-17.5M	13.7M	-12.7M	-1.2B	4.8M	-565K
Pretax income	-458.5M	-142.1M	-41.6M	202.4M	112.3M	-1.3B	-128M	-5M
Income tax	-45.8M	-35.7M	-3.3M	53.5M	35.3M	-27.6M	-7.5M	6.3M
Net income	-413.8M	-104M	-31.7M	159.8M	89.9M	-1.3B	-101.8M	9.1M
Net margin	-9.42%	-2.34%	-0.65%	2.75%	1.49%	-20.5%	-1.66%	0.15%
EBITDA	345.9M	303.5M	369.9M	473.1M	407.8M	251.1M	215.3M	323.4M
EPS	-1.4	-0.33	-0.13	0.62	0.34	-4.78	-0.37	0.03
Diluted EPS	-1.4	-0.33	-0.13	0.62	0.34	-4.78	-0.37	0.03

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27	Q2 27
Revenue	1.5B	1.7B	1.5B	1.5B	1.5B	1.6B	1.5B	1.5B	1.5B	1.5B	1.5B	1.5B
Cost of revenue	944.2M	1.1B	950.5M	943M	935.7M	962.9M	923.4M	903.2M	895.4M	934.4M	922.3M	898.1M
Gross profit	550M	606.3M	578.7M	580.7M	575.8M	589.3M	570M	585.3M	569M	580.8M	574.4M	591.1M
Gross margin	36.8%	36.2%	37.8%	38.1%	38.1%	38%	38.2%	39.3%	38.9%	38.3%	38.4%	39.7%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	559.6M	606.2M	595.4M	578.3M	571.8M	571.9M	553.6M	542.3M	539.8M	548.9M	549.8M	543.3M
Operating expenses	559.6M	606.2M	595.4M	578.3M	571.8M	571.9M	553.6M	542.3M	539.8M	548.9M	549.8M	543.3M
Operating income	-9.6M	166K	-16.8M	2.5M	4M	17.4M	16.4M	43M	29.2M	31.9M	24.6M	47.8M
Operating margin	-0.64%	0.01%	-1.1%	0.16%	0.26%	1.12%	1.1%	2.89%	1.99%	2.1%	1.65%	3.21%
Non-operating income, net	-1.2B	0	-2.7M	—	8.5M	-1M	—	—	—	—	-11.8M	—
Pretax income	-1.3B	-39.2M	-55.8M	-33.7M	-22M	-16.4M	-15.8M	10.6M	-1.8M	1.9M	-18.5M	17.7M
Income tax	-22.9M	-10.4M	-4.5M	-4.7M	-857K	2.5M	495K	746K	-6.3M	11.3M	2.2M	-15.7M
Net income	-1.2B	-22.6M	-46.5M	-24.8M	-16.7M	-13.8M	-11.7M	14M	9.3M	-2.6M	-15.1M	38.7M
Net margin	-83.1%	-1.35%	-3.04%	-1.63%	-1.1%	-0.89%	-0.78%	0.94%	0.64%	-0.17%	-1.01%	2.6%
EBITDA	42.3M	52.7M	30.6M	52.9M	63.9M	68M	67.1M	92.8M	80.3M	81.8M	75.2M	100.7M
EPS	-4.63	-0.08	-0.17	-0.09	-0.06	-0.05	-0.04	0.05	0.03	-0.01	-0.05	0.14
Diluted EPS	-4.63	-0.08	-0.17	-0.09	-0.06	-0.05	-0.04	0.05	0.03	-0.01	-0.05	0.13

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Market cap	—	—	—	—	3.1B	639.4M	935.1M	752M	650.2M
Enterprise value	—	—	—	—	6B	3.5B	3.7B	3.4B	3.2B
Shares outstanding	294.8M	294.8M	210.7M	264.3M	265.5M	267.5M	273.4M	279.6M	279.6M

Valuation

Metric	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
P/E	—	—	—	—	34.5	—	—	82.9	22.7
P/S	—	—	—	—	0.51	0.1	0.15	0.13	0.11
P/B	—	—	—	—	1.3	0.54	0.84	0.65	0.54
EV/EBITDA	—	—	—	—	14.8	14.1	17.2	10.4	9.56
EV/Sales	—	—	—	—	1	0.57	0.61	0.56	0.53
Earnings yield	—	—	—	—	2.9%	—	—	1.21%	4.41%
FCF yield	—	—	—	—	2.19%	-1.54%	5.31%	24.9%	24.7%
PEG	—	—	—	—	—	—	—	—	0.13

Profitability

Metric	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Gross margin	43.4%	43%	42.8%	41.8%	40.2%	37.6%	38%	38.7%	39.7%
Operating margin	3.61%	2.92%	3.95%	4.58%	3.74%	0.67%	0.12%	2.02%	3.21%
Net margin	-9.42%	-2.34%	-0.65%	2.75%	1.49%	-20.5%	-1.66%	0.15%	0.51%
ROE	-64.9%	-18.5%	-1.54%	7.08%	3.78%	-108.1%	-9.14%	0.78%	2.58%
ROA	-8.4%	-1.69%	-0.52%	2.46%	1.36%	-23.9%	-1.96%	0.18%	1.64%
ROIC	4.3%	2.54%	3.93%	3.84%	2.91%	1.03%	0.18%	3.19%	3.57%
Return on tangible assets	23.3%	40.3%	9.53%	199.9%	51.4%	-94.7%	-8.6%	0.78%	2.62%

Financial health

Metric	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Current ratio	1.4	0.84	0.89	1.02	0.99	0.86	0.85	0.9	0.9
Quick ratio	0.54	0.28	0.27	0.38	0.36	0.24	0.28	0.38	0.39
Debt / equity	5.06	8.36	1.46	1.35	1.32	2.56	2.64	2.46	2.34
Debt / assets	0.66	0.76	0.49	0.47	0.47	0.56	0.57	0.55	0.55
Net debt / EBITDA	8.8	15	7.81	6	7.19	11.6	12.9	8.07	7.48
Interest coverage	-0.88	0.44	0.81	3.62	2.1	-7.77	0.11	0.96	1
Effective tax rate	0%	0%	0%	26.4%	31.5%	0%	0%	0%	0%

Per share

Metric	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Revenue per share	14.9	15	23.4	22	22.7	23.4	22.4	21.3	21.1
EPS (basic)	-1.4	-0.33	-0.13	0.62	0.34	-4.78	-0.37	0.03	0.03
EPS (diluted)	-1.4	-0.33	-0.13	0.62	0.34	-4.78	-0.37	0.03	0.1
Book value per share	2.16	1.9	9.75	8.54	8.97	4.43	4.07	4.16	4.22
FCF per share	0.19	-0.16	0.52	0.45	0.26	-0.04	0.18	0.67	0.82
Cash per share	0.61	0.5	0.53	0.8	0.76	0.47	0.61	0.92	1.03
Capex per share	0.49	0.47	0.76	0.9	1.05	0.84	0.47	—	—

Capital allocation

Metric	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Capex / revenue	3.32%	3.12%	3.24%	4.12%	4.61%	3.61%	2.09%	—	—
Capex / operating cash flow	-116.3%	102.3%	61.7%	90.7%	69.2%	-24.1%	72.1%	—	—
Payout ratio	—	—	—	—	—	—	—	—	0%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Cash & short-term investments	180.6M	148.8M	111.4M	211.6M	201.9M	125.4M	165.8M	256.7M
Receivables	27.9M	31.5M	41.8M	55.6M	49.6M	44.4M	40.4M	45.8M
Inventory	470.1M	479M	538.7M	675.1M	652.4M	684.5M	653.3M	590.2M
Total current assets	761.6M	711M	777.5M	1.1B	1B	951.7M	973.6M	1B
Property, plant & equipment	645.1M	2.1B	1.9B	2B	2.2B	2.2B	2B	1.9B
Goodwill & intangibles	6.7B	6.4B	6.4B	6.4B	6.4B	4B	4B	4B
Total assets	4.9B	6.2B	6.1B	6.5B	6.6B	5.4B	5.2B	5.2B
Accounts payable	276.9M	293.2M	339.5M	404M	381.2M	485.1M	492.9M	450.6M
Short-term debt	28.4M	306.9M	260.5M	287.7M	332.6M	326.5M	311.7M	324.7M
Total current liabilities	543.5M	841.9M	875.3M	1.1B	1B	1.1B	1.1B	1.1B
Long-term debt	3.2B	4.4B	2.7B	2.8B	2.8B	2.7B	2.6B	2.5B
Total liabilities	4.3B	5.6B	4B	4.2B	4.2B	4.2B	4.1B	4B
Shareholders' equity	637.9M	561.1M	2.1B	2.3B	2.4B	1.2B	1.1B	1.2B
Total debt	3.2B	4.7B	3B	3B	3.1B	3B	2.9B	2.9B
Net debt	3B	4.5B	2.9B	2.8B	2.9B	2.9B	2.8B	2.6B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27	Q2 27
Cash & short-term investments	139.8M	125.4M	89.7M	127.6M	116.7M	165.8M	133.3M	188.7M	237.4M	256.7M	166.8M	293.5M
Receivables	50.2M	44.4M	42.1M	47M	40.4M	40.4M	36.1M	34.5M	42.9M	45.8M	36.9M	38.4M
Inventory	730.1M	684.5M	681M	672.3M	690.3M	653.3M	645.5M	608.5M	617.9M	590.2M	632.9M	601.6M
Total current assets	1B	951.7M	904.1M	941.9M	931.8M	973.6M	920.4M	939.6M	1B	1B	960.8M	1.1B
Property, plant & equipment	2.2B	2.2B	2.1B	2.1B	2.1B	2B	2B	2B	2B	1.9B	1.9B	1.9B
Goodwill & intangibles	4B	4B	4B	4B	4B	4B	4B	4B	4B	4B	4B	4B
Total assets	5.4B	5.4B	5.3B	5.3B	5.2B	5.2B	5.1B	5.2B	5.2B	5.2B	5.1B	5.2B
Accounts payable	486.6M	485.1M	464.5M	474.5M	447.7M	492.9M	473.9M	423.3M	430M	450.6M	480.7M	455.3M
Short-term debt	311.1M	326.5M	311.7M	311.6M	345.7M	311.7M	310.4M	312.4M	351.8M	324.7M	325.6M	352.7M
Total current liabilities	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.2B
Long-term debt	2.7B	2.7B	2.7B	2.7B	2.6B	2.6B	2.6B	2.6B	2.6B	2.5B	2.5B	2.5B
Total liabilities	4.2B	4.2B	4.1B	4.1B	4.1B	4.1B	4B	4B	4B	4B	3.9B	4B
Shareholders' equity	1.2B	1.2B	1.2B	1.1B	1.1B	1.1B	1.1B	1.1B	1.2B	1.2B	1.2B	1.2B
Total debt	3B	3B	3B	3B	3B	2.9B	2.9B	2.9B	3B	2.9B	2.8B	2.8B
Net debt	2.9B	2.9B	2.9B	2.9B	2.9B	2.8B	2.8B	2.8B	2.7B	2.6B	2.6B	2.5B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Net income	-413.8M	-104M	-31.7M	159.8M	89.9M	-1.3B	-101.8M	9.1M
Depreciation & amortization	187M	173.5M	174.8M	172.4M	193.8M	200.8M	199.7M	196.7M
Stock-based compensation	8.5M	9.5M	12.9M	49.3M	60.8M	81.9M	50.2M	32.6M
Change in working capital	68.8M	-412.9M	-362.5M	-511.6M	-383.5M	-366.9M	-382M	-360.4M
Operating cash flow	-125.3M	135.3M	258.5M	263.7M	401.6M	-935.7M	177.5M	314.1M
Capital expenditure	-145.8M	-138.4M	-159.6M	-239.1M	-278M	-225.6M	-128M	—
Investing cash flow	-142.4M	-138.6M	-157.2M	-237.1M	-320.3M	-207.4M	-123.9M	2.5M
Dividends paid	—	—	—	—	—	—	—	—
Share repurchases	-111K	0	-105K	0	0	—	—	—
Financing cash flow	-32.1M	-3.1M	-146.6M	-23M	-37.6M	-89.6M	-12.5M	-105.4M
Net change in cash	-299.8M	-6.4M	-45.3M	3.6M	43.7M	-1.2B	41.1M	211.2M
Free cash flow	54.8M	-47M	109.1M	119.1M	68M	-9.9M	49.7M	187M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27	Q2 27
Net income	-1.2B	-22.6M	-46.5M	-24.8M	-16.7M	-13.8M	-11.7M	14M	9.3M	-2.6M	-15.1M	38.7M
Depreciation & amortization	50.7M	52.2M	49.6M	49.7M	50.1M	50.3M	49.4M	48.8M	49.3M	48.2M	49M	50.4M
Stock-based compensation	18.2M	17.4M	17.4M	11.9M	11.4M	9.5M	9.4M	8.8M	7.2M	7.3M	9.5M	8.6M
Change in working capital	-113.7M	-79.3M	-116.5M	-91M	-108.2M	-66.3M	-112M	-115.1M	-77.8M	-55.6M	-142.3M	-79.5M
Operating cash flow	-1.2B	80.6M	10.4M	49.9M	32.3M	84.8M	38.3M	85.9M	90.1M	153.5M	-31M	161.6M
Capital expenditure	-62.5M	-49.1M	-32.6M	-27.4M	-31M	-36.9M	-28.4M	—	—	—	—	—
Investing cash flow	-50.3M	-51.3M	-31.7M	-27.5M	-31M	-34.4M	-27.1M	1.1M	116K	0	304K	192K
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	—	—	—	—	—	—	—	—	—	—	—	—
Financing cash flow	-19.1M	-2.2M	-6.5M	-3.6M	-2.9M	-2.1M	-1.3M	-5M	-1.8M	-97.3M	-33.6M	-4.5M
Net change in cash	-1.2B	27.1M	-27.8M	18.8M	-1.5M	48.3M	9.9M	82.1M	88.4M	56.2M	-64.3M	157.3M
Free cash flow	-28.1M	-2M	-41.1M	42M	-10.3M	59M	-43.9M	53.8M	60.6M	116.4M	-69.1M	129.9M

Petco Health and Wellness Company, Inc. Class A Common Stock Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement